Promoting health equity in the era of COVID-19

Farley, John H.; Hines, Jeffrey F.; Lee, Nita K.; Brooks, Sandra E.; Nair, Navya; Brown, Carol L.; Doll, Kemi M.; Sullivan, Ellen J.; Chapman‐Davis, Eloise

doi:10.1016/j.ygyno.2020.05.023

Cited by 22 publications

(41 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Emerging data suggest that the COVID-19 pandemic has disproportionately affected many minority and marginalized populations in the U.S. and future studies focused on more diverse populations are needed. [44,45] All of these selection biases could have skewed our findings. However, our study did include a large number of J o u r n a l P r e -p r o o f ovarian cancer survivors with diversity in geographic location, age, education and spectrum on the treatment continuum and, to our knowledge, is one of the first reports on coping mechanisms utilized by people living with cancer during the COVID-19 crisis.…”

Section: Resultsmentioning

confidence: 95%

Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic

Frey

Chapman‐Davis

Glynn

et al. 2021

Gynecologic Oncology

Self Cite

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

Section: Resultsmentioning

confidence: 95%

Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic

Frey

Chapman‐Davis

Glynn

et al. 2021

Gynecologic Oncology

Self Cite

View full text Add to dashboard Cite

show abstract

“…Prior studies demonstrate health inequities across the five boroughs of New York City and suggest that the COVID-19 pandemic has disproportionately affected many minority and marginalized populations. [ [19] , [20] , [21] ] Early studies of COVID-19 demonstrate higher rates of COVID-19 hospitalizations and deaths in the boroughs with greater representation of racial/ethnic minorities. The boroughs, in order of decreasing COVID-19 hospitalizations and deaths, were the Bronx, Queens, Brooklyn, Staten Island and Manhattan [ 22 , 23 ].…”

Section: Discussionmentioning

confidence: 99%

Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals

Frey

Fowlkes

Badiner

et al. 2020

Gynecologic Oncology

Self Cite

View full text Add to dashboard Cite

Background New York City was among the epicenters during the COVID-19 pandemic. Oncologists must balance plausible risks of COVID-19 infection with the recognized consequences of delaying cancer treatment, keeping in mind the capacity of the health care system. We sought to investigate treatment patterns in gynecologic cancer care during the first two months of the COVID-19 pandemic at three affiliated New York City hospitals located in Brooklyn, Manhattan and Queens. Methods A prospective registry of patients with active or presumed gynecologic cancers receiving inpatient and/or outpatient care at three affiliated New York City hospitals was maintained between March 1 and April 30, 2020. Clinical and demographic data were abstracted from the electronic medical record with a focus on oncologic treatment. Multivariable logistic regression analysis was explored to evaluate the independent effect of hospital location, race, age, medical comorbidities, cancer status and COVID-19 status on treatment modifications. Results Among 302 patients with gynecologic cancer, 117 (38.7%) experienced a COVID-19-related treatment modification (delay, change or cancellation) during the first two months of the pandemic in New York. Sixty-four patients (67.4% of those scheduled for surgery) had a COVID-19-related modification in their surgical plan, 45 (21.5% of those scheduled for systemic treatment) a modification in systemic treatment and 12 (18.8% of those scheduled for radiation) a modification in radiation. Nineteen patients (6.3%) had positive COVID-19 testing. On univariate analysis, hospital location in Queens or Brooklyn, age ≤65 years, treatment for a new cancer diagnosis versus recurrence and COVID-19 positivity were associated with treatment modifications. On multivariable logistic regression analysis, hospital location in Queens and COVID-19 positive testing were independently associated with treatment modifications. Conclusions More than one third of patients with gynecologic cancer at three affiliated New York City hospitals experienced a treatment delay, change or cancellation during the first two months of the COVID-19 pandemic. Among the three New York City boroughs represented in this study, likelihood of gynecologic oncology treatment modifications correlated with the case burden of COVID-19.

show abstract

“…The exacerbation in financial toxicity for these patients may be unsurmountable and the already existing gap in health inequities may be wider because of the pandemic's effect. [22][23][24][25] Therefore, it is of utmost importance that we identify innovative ways to address these challenges by allocating resources for patients who need cancer therapy but may not be able to afford their treatment. In addition to the patients who are already under our care, we also need to remember that cancer screening has been halted across the globe, as seen by the data from the Netherlands, which documented a decrease in cancer diagnoses between late February and April 2020.…”

Section: Discussion/conclusionmentioning

confidence: 99%

Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?

Cinar

Bold

Bosslet

et al. 2020

CA A Cancer J Clinicians

View full text Add to dashboard Cite

The delivery of cancer care has never changed as rapidly and dramatically as we have seen with the coronavirus disease 2019 (COVID-19) pandemic. During the early phase of the pandemic, recommendations for the management of oncology patients issued by various professional societies and government agencies did not recognize the significant regional differences in the impact of the pandemic. California initially experienced lower than expected numbers of cases, and the health care system did not experience the same degree of the burden that had been the case in other parts of the country. In light of promising trends in COVID-19 infections and mortality in California, by late April 2020, discussions were initiated for a phased recovery of full-scale cancer services. However, by July 2020, a surge of cases was reported across the nation, including in California. In this review, the authors share the response and recovery planning experience of the University of California (UC) Cancer Consortium in an effort to provide guidance to oncology practices. The UC Cancer Consortium was established in 2017 to bring together 5 UC Comprehensive

show abstract

Promoting health equity in the era of COVID-19

Cited by 22 publications

References 11 publications

Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic

Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic

Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals

Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?

Contact Info

Product

Resources

About